熱門資訊> 正文
Relay Therapeutics股票发行价为2亿美元
2024-09-11 14:31
- Clinical-stage precision medicine company Relay Therapeutics (NASDAQ:RLAY) priced an underwritten public offering of ~28.57M shares at $7.00 per share.
- Underwriters have a 30-day option to purchase up to an additional ~4.29M shares of its common stock.
- Gross proceeds are expected to be ~$200M.
- The offering is expected to close on or about September 12, 2024.
- The stock price was down 1.6% on Tuesday after hours of trade.
More on Relay Therapeutics
- Relay Therapeutics: A 'Concept' Stock
- Relay upgraded by Jefferies, downgraded by Oppenheimer
- Relay stock rallies 41% on positive data for RLY-2608
- Seeking Alpha’s Quant Rating on Relay Therapeutics
- Historical earnings data for Relay Therapeutics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
